18343245

Source:http://linkedlifedata.com/resource/pubmed/id/18343245

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0020443, umls-concept:C0030705, umls-concept:C0034656, umls-concept:C0065055, umls-concept:C0082608, umls-concept:C0205195, umls-concept:C0205225, umls-concept:C0333348, umls-concept:C0549193, umls-concept:C1142985, umls-concept:C1280500, umls-concept:C2603343
pubmed:issue	1
pubmed:dateCreated	2008-3-17
pubmed:abstractText	Combining lipid-lowering agents with complementary mechanisms of action can provide greater cholesterol reductions than using either agent alone, improving achievement of target low-density lipoprotein cholesterol (LDL-C) levels.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7706726
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anticholesteremic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins B, http://linkedlifedata.com/resource/pubmed/chemical/Azetidines, http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL, http://linkedlifedata.com/resource/pubmed/chemical/Delayed-Action Preparations, http://linkedlifedata.com/resource/pubmed/chemical/Fatty Acids, Monounsaturated, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA..., http://linkedlifedata.com/resource/pubmed/chemical/Indoles, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1beta, http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides, http://linkedlifedata.com/resource/pubmed/chemical/ezetimibe, http://linkedlifedata.com/resource/pubmed/chemical/fluvastatin
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	1879-114X
pubmed:author	pubmed-author:Alvarez-SalaLuis ALA, pubmed-author:CachofeiroVictoriaV, pubmed-author:GambusGemmaG, pubmed-author:LaheraVicenteV, pubmed-author:MasanaLuisL, pubmed-author:MorenoMiguel AngelMA, pubmed-author:PinillaBlancaB, pubmed-author:PintóXavierX, pubmed-author:PlanaNuriaN, pubmed-author:SuarezCarmenC, pubmed-author:TriasFerranF
pubmed:issnType	Electronic
pubmed:volume	30
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	84-97
pubmed:dateRevised	2009-9-18
pubmed:meshHeading	pubmed-meshheading:18343245-Anticholesteremic Agents, pubmed-meshheading:18343245-Apolipoproteins B, pubmed-meshheading:18343245-Azetidines, pubmed-meshheading:18343245-Biological Markers, pubmed-meshheading:18343245-C-Reactive Protein, pubmed-meshheading:18343245-Cholesterol, pubmed-meshheading:18343245-Cholesterol, LDL, pubmed-meshheading:18343245-Delayed-Action Preparations, pubmed-meshheading:18343245-Drug Therapy, Combination, pubmed-meshheading:18343245-Fatty Acids, Monounsaturated, pubmed-meshheading:18343245-Female, pubmed-meshheading:18343245-Humans, pubmed-meshheading:18343245-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:18343245-Hypercholesterolemia, pubmed-meshheading:18343245-Indoles, pubmed-meshheading:18343245-Interleukin-1beta, pubmed-meshheading:18343245-Male, pubmed-meshheading:18343245-Middle Aged, pubmed-meshheading:18343245-Triglycerides
pubmed:year	2008
pubmed:articleTitle	Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
pubmed:affiliation	Lipids Unit, Hospital Universitario Gregorio Marañón, Madrid, Spain. lalvarezsalaw@medynet.com
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Multicenter Study